ATE340184T1 - Makrolidantibiotika - Google Patents
MakrolidantibiotikaInfo
- Publication number
- ATE340184T1 ATE340184T1 AT01271381T AT01271381T ATE340184T1 AT E340184 T1 ATE340184 T1 AT E340184T1 AT 01271381 T AT01271381 T AT 01271381T AT 01271381 T AT01271381 T AT 01271381T AT E340184 T1 ATE340184 T1 AT E340184T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- macrolide antibiotic
- solvates
- prophylaxis
- systemic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0031312.2A GB0031312D0 (en) | 2000-12-21 | 2000-12-21 | Macrolides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE340184T1 true ATE340184T1 (de) | 2006-10-15 |
Family
ID=9905640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01271381T ATE340184T1 (de) | 2000-12-21 | 2001-12-20 | Makrolidantibiotika |
Country Status (9)
Country | Link |
---|---|
US (1) | US6900183B2 (de) |
EP (1) | EP1343797B1 (de) |
JP (1) | JP2004520314A (de) |
AT (1) | ATE340184T1 (de) |
AU (1) | AU2002222296A1 (de) |
DE (1) | DE60123277T2 (de) |
ES (1) | ES2272410T3 (de) |
GB (1) | GB0031312D0 (de) |
WO (1) | WO2002050092A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024986A1 (en) * | 2001-09-17 | 2003-03-27 | Ortho-Mcneil Pharmaceutical, Inc. | 6-o-carbamate-11,12-lacto-ketolide antimicrobials |
US6995143B2 (en) | 2002-02-28 | 2006-02-07 | Basilea Pharmaceutica Ag | Macrolides with antibacterial activity |
US6727229B2 (en) | 2002-08-19 | 2004-04-27 | Enanta Pharmaceuticals, Inc. | 11,12-substituted lactone ketolide derivatives having antibacterial activity |
US6720308B1 (en) * | 2002-11-07 | 2004-04-13 | Enanta Pharmaceuticals, Inc. | Anhydrolide derivatives having antibacterial activity |
CA2529817C (en) | 2003-03-10 | 2013-02-12 | Optimer Pharmaceuticals, Inc. | Novel antibacterial agents |
US20040254126A1 (en) * | 2003-06-05 | 2004-12-16 | Yao-Ling Qiu | 11-12 Bicyclic erythromycin derivatives |
US6774115B1 (en) | 2003-06-05 | 2004-08-10 | Enanta Pharmaceuticals, Inc. | 6-O-substituted bicyclic ketolides |
US6716820B1 (en) | 2003-06-05 | 2004-04-06 | Enanta Pharmaceuticals, Inc. | 6-O-substituted bicyclic macrolides |
WO2004108745A2 (en) * | 2003-06-05 | 2004-12-16 | Enanta Pharmaceuticals, Inc. | 11-12 bicyclic erythromycin derivatives |
US6765016B1 (en) | 2003-06-05 | 2004-07-20 | Enanta Pharmaceuticals, Inc. | Bicyclic ketolide derivatives |
US6790835B1 (en) | 2003-06-05 | 2004-09-14 | Enanta Pharmaceuticals, Inc. | Bicyclic macrolide derivatives |
EP1879903A1 (de) | 2005-05-10 | 2008-01-23 | GlaxoSmithKline istrazivacki centar Zagreb d.o.o. | Etherverbrückte makrolide, die sich zur behandlung mikrobieller infektionen eignen |
US8124744B2 (en) * | 2006-05-01 | 2012-02-28 | Taisho Pharmaceutical Co., Ltd. | Macrolide derivatives |
WO2008023248A2 (en) | 2006-08-24 | 2008-02-28 | Wockhardt Research Centre | Novel macrolides and ketolides having antimicrobial activity |
CN101917850B (zh) | 2007-10-25 | 2016-01-13 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
WO2010048599A1 (en) | 2008-10-24 | 2010-04-29 | Cempra Pharmaceuticals, Inc. | Methods for treating gastrointestinal diseases |
BRPI1011959A2 (pt) | 2009-05-27 | 2016-04-26 | Wockhardt Research Center | compostos de cetolídeo tendo atividade antimicrobiana. |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
JP5914335B2 (ja) | 2009-09-10 | 2016-05-11 | センプラ ファーマシューティカルズ,インコーポレイテッド | マラリア、結核、及びmac病の治療方法 |
NZ602544A (en) | 2010-03-22 | 2014-11-28 | Cempra Pharmaceuticals Inc | Crystalline forms of a macrolide, and uses therefor |
US9051346B2 (en) | 2010-05-20 | 2015-06-09 | Cempra Pharmaceuticals, Inc. | Process for preparing triazole-containing ketolide antibiotics |
JP6042334B2 (ja) | 2010-09-10 | 2016-12-14 | センプラ ファーマシューティカルズ,インコーポレイテッド | 疾患治療のための水素結合形成フルオロケトライド |
PL2673285T3 (pl) | 2010-12-09 | 2017-12-29 | Wockhardt Limited | Związki ketolidowe |
JP5718488B2 (ja) | 2011-03-01 | 2015-05-13 | ウォックハート リミテッド | ケトライド中間体の調製方法 |
SG11201405895UA (en) | 2012-03-27 | 2014-10-30 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
US9861616B2 (en) | 2013-03-14 | 2018-01-09 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
JP6675973B2 (ja) | 2013-03-15 | 2020-04-08 | センプラ ファーマシューティカルズ,インコーポレイテッド | マクロライド抗菌薬を調製するための集束的な方法 |
MX2018010652A (es) | 2016-01-12 | 2021-07-16 | Wockhardt Ltd | Composiciones farmaceuticas. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2739620B1 (fr) * | 1995-10-09 | 1997-12-19 | Roussel Uclaf | Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs |
US6124269A (en) * | 1997-10-29 | 2000-09-26 | Abbott Laboratories | 2-Halo-6-O-substituted ketolide derivatives |
DK1161438T3 (da) | 1999-03-15 | 2004-08-30 | Abbott Lab | 6-O-substituerede makrolider, som har antibakteriel aktivitet |
EP1114826A3 (de) * | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Antibakterielle und prokinetische Makroliden |
-
2000
- 2000-12-21 GB GBGB0031312.2A patent/GB0031312D0/en not_active Ceased
-
2001
- 2001-12-20 ES ES01271381T patent/ES2272410T3/es not_active Expired - Lifetime
- 2001-12-20 JP JP2002551985A patent/JP2004520314A/ja not_active Ceased
- 2001-12-20 EP EP01271381A patent/EP1343797B1/de not_active Expired - Lifetime
- 2001-12-20 US US10/450,886 patent/US6900183B2/en not_active Expired - Fee Related
- 2001-12-20 AT AT01271381T patent/ATE340184T1/de not_active IP Right Cessation
- 2001-12-20 AU AU2002222296A patent/AU2002222296A1/en not_active Abandoned
- 2001-12-20 DE DE60123277T patent/DE60123277T2/de not_active Expired - Fee Related
- 2001-12-20 WO PCT/GB2001/005669 patent/WO2002050092A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE60123277T2 (de) | 2007-09-13 |
JP2004520314A (ja) | 2004-07-08 |
DE60123277D1 (de) | 2006-11-02 |
GB0031312D0 (en) | 2001-02-07 |
EP1343797A1 (de) | 2003-09-17 |
US20040082526A1 (en) | 2004-04-29 |
US6900183B2 (en) | 2005-05-31 |
WO2002050092A1 (en) | 2002-06-27 |
ES2272410T3 (es) | 2007-05-01 |
EP1343797B1 (de) | 2006-09-20 |
AU2002222296A1 (en) | 2002-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE340184T1 (de) | Makrolidantibiotika | |
AP9801253A0 (en) | 9-Oxime erythromycin derivatives. | |
RS41904A (en) | Macrolides | |
CA2316919A1 (en) | Novel macrolides | |
BG103969A (en) | C-4"-substituted macrolide derivatives | |
MXPA03005464A (es) | Agentes antivirales. | |
TR199901127T2 (xx) | Antibakteriyel etkili 6-O-ikameli ketolitler. | |
AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
CA2292359A1 (en) | Novel azalides and methods of making same | |
CA2359708A1 (en) | Ketolide antibiotics | |
PT806941E (pt) | Composicoes anti-bacterianas liposomicas de rigidez baixa | |
CA2351429A1 (en) | 13-membered azalides and their use as antibiotic agents | |
ATE164848T1 (de) | 4''-deoxyerythromycinderivate | |
AU6484199A (en) | Carbamate and carbazate ketolide antibiotics | |
DK0992509T3 (da) | Nye makrolid-derivater | |
CA2280328A1 (en) | C11 carbamates of macrolide antibacterials | |
BR9708929A (pt) | Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos | |
WO2004039822A3 (en) | 4’’ - modified erythromycin derivatives | |
AP2001002325A0 (en) | Novel crystalline forms of a macrolide antibiotic | |
AP9801235A0 (en) | Erythromycin derivatives. | |
WO2002018354A8 (en) | Oxazolidinones and their use as antibacterial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |